cardiologia

ISTRUZIONE E FORMAZIONE:

• gennaio 2020 – febbraio 2022: Cardiologo interventista, IRCCS Ospedale San Matteo, Divisione di Cardiologia, Pavia
• luglio 2018 – dicembre 2018: borsa di studio in cardiologia interventistica presso Hart Long Centrum Leiden, Leida, Paesi Bassi
• dicembre 2014 – dicembre 2019: Università degli Studi di Pavia, Divisione di Cardiologia, Pavia Residenza – “con Lode”
• giugno 2014: Centro di Formazione per l'Emergenza, Ospedale S.Camillo Forlanini, Roma, Corso per operatori ALS, Certificato di operatore europeo ALS
• Febbraio 2014: “Università Cattolica del Sacro Cuore”, Facoltà di Medicina e Chirurgia, Roma, Abilitazione all'esercizio della professione medica
• ottobre 2007-luglio 2013, “Università Cattolica del Sacro Cuore”, Facoltà di Medicina e Chirurgia, Roma, Laurea – “con Lode”
• ottobre 2011 – giugno 2014: Istituto di Cardiologia, “Università Cattolica del Sacro Cuore”, Roma, tirocinio
• Maggio 2013: Istituto di Anestesia e Terapia Intensiva, “Università Cattolica del Sacro Cuore”, Roma, corso BLS-D, certificato BLS-D provider
• agosto 2012: Scuola di Medicina dell'Università KOC, Istanbul, Scuola Estiva Internazionale sulle Malattie Cardiovascolari, Certificato di partecipazione
• maggio 2012: Istituto di Cardiologia, “Università Cattolica del Sacro Cuore”, Roma, Corso di interpretazione ECG, Certificato di partecipazione
• dicembre 2011-febbraio 2012: Istituto di Radiodiagnostica, “Università Cattolica del Sacro Cuore”, Roma, Corso di Ecografia, Certificato di partecipazione
• ottobre 2009-luglio 2010: Istituto di Anatomia Umana, “Università Cattolica del Sacro Cuore”, Attività di tirocinio e mentoring per gli studenti
• Settembre 2002- Luglio 2007: Liceo Classico “G.Palmieri”, Lecce, Maturità - Voto 100/100

PUBBLICAZIONI PEER REVIEW

• Mandurino Mirizzi A, Niccoli G Prevenzione e trattamento del no-reflow: siamo ancora fermi? Giornale italiano di Cardiologia Invasiva 2013; 3: 29-38.
• Melpignano A, Mandurino Mirizzi A, Besagni F, Leri A. Dermatologic manifestations and neuropathic symptoms in women with Fabry disease Acta Biomedica 2014; 85:81-84.
• Montone R, Mandurino Mirizzi A, Niccoli G. Neoatherosclerosis: a novel player in late stent failure Interventional Cardiology 2014; 2:217-225.
• Mandurino Mirizzi A, Niccoli G. No reflow dopo angioplastica primaria: strategie di prevenzione e trattamento Gruppo di studio Aterosclerosi, Trombosi, Biologia Vascolare 2014 March 14.
• Niccoli G, Scalone G, Cosentino N, Fabretti A, Mandurino Mirizzi A, Gramegna M, Panebianco M, Roberto M, Crea F Protective effect of pre-infarction angina on microvascular obstruction after primary percutaneous coronary intervention is blunted in humans by cardiovascular risk factors. Circulation Journal 2014;78(8):1935-41.
• Niccoli G, Milardi D, D’Amario D, Fracassi F, Grande G, Antonazzo PR, Roberto M, Mandurino Mirizzi A, Canu G, De Marinis L, Carrozza C, Pontecorvi A, Crea F Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction. European Journal of Preventive Cardiology 2015;22(7):855-63.
• Niccoli G, Cosentino N, Spaziani C, Loria V, Fracassi F, Mandurino Mirizzi A. Lombardo A, Natale L, Napolitano C, Burzotta F, Leone AM, Porto I, Trani C, Bonomo L, Crea F. Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial hemorrhage role Journal of Cardiovascular Medicine 2016;17(5):382-91
• Mandurino Mirizzi A, Leonardi S, Melloni C. Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes. Minerva Endocrinologica 2017;42(3):228-237.
• Mandurino Mirizzi A, Crimi G. Contrast-induced Acute Kidney Injury: A Review. Frontiers in Medicine and Health Research 2017; 1(1): 1-8.
• Mandurino Mirizzi A, Crimi G, Raineri C, Pica S, Ruffinazzi M, Gianni U, Repetto A, Ferlini M, Marinoni B, Leonardi S, De Servi S, Oltrona-Visconti L, De Ferrari GM and Ferrario M. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Journal of Cardiovascular Medicine 2018; 19 (5): 240-246.
• Mandurino Mirizzi A, Demarchi A, Crimi G, Ruffinazzi M, Camporotondo R, Ferrario M, De Ferrari GM. Serum uric acid may modulate the inflammatory response after primary PCI in patients with ST-elevation myocardial infarction. Minerva Cardioangiologica 2018; Vol 66 Suppl 1 Fasc 3.
• Calogiuri G, Mandurino-Mirizzi A, Parlangeli C, Macchia L, Foti C, Savage PM. Comparing allergist and cardiologist considerations for the optimal management of thienopyridines hypersensitivity. Endocr Metab Immune Disord drug targets 2018 Sep 14.
• Fracassi F, Vetrugno V, Mandurino-Mirizzi A, Cosentino N, Panicale S, Caprari P, Niccoli G, Crea F. Effect of hemorheological parameters on myocardial injury after primary or elective percutaneous coronary intervention. Coronary artery disease 2018; 29(8): 638-646.
• Crimi G, Morici N, Ferrario M, Ferri LA, Piatti L, Grosseto D, Cacucci M, Mandurino Mirizzi A, Toso A, Piscione F, De Carlo M, Elia LR, Trimarco B, Bolognese L, BovenziFM, De Luca G, Savonitto S, De Servi S. Time course of ischemic and bleeding burden in elderly patients with acute coronary syndromes randomized to low-dose prosugrel or clopidogrel. J Am Heart Assoc 2019 22; 8 (2) e010956
• Crimi G, Fortuni F, Mandurino Mirizzi A, Gritti V, Leonardi S, De Ferrari GM. Primum non nocer: an updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes. Eur J Preventive Cardiol 2019 Feb
• Crimi G, Moramarco L, Mandurino-Mirizzi A, Quaretti P, Ferrario M. The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion therapy in a patient with embolic myocardial infarction. Catheter Cardiovasc Interv 2019; 94 (2):E78-E81.
• Somaschini A, Demarchi A, Cornara S, Mandurino Mirizzi A, Crimi G, Ferlini M, Gnecchi M, Camporotondo R, Oltrona Visconti L, Ferrario Ormezzano M, De Ferrari GM. Smoker’s paradox in ST-elevation myocardial infarction: Role of inflammation and platelets. Hellenic J Cardiol 2019 60 (6):397-399.
• Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG. Omalizumab For The Treatment of Persistent Drug Induced Urticaria Elicited By Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem 2019 May.
• Crimi G, Mandurino-Mirizzi A, Gritti V, Scotti V, Strozzi C, De Silvestri A, Montalto C, Di Giacomo C, D’Ascenzo F, Repetto A, Ferlini M, Marinoni B, Ferrario M, De Servi S, Oltrona Visconti L, Klersy C. Percutaneous coronary intervention techniques for bifurcation disease: network meta-analysis reveals superiority of double-kissing crush. Can J Cardiol 2020 Jun;36(6):906-914.
• Crimi G, Montalto C, Ferri LA, Piatti L, Bossi I, Morici N, Mandurino-Mirizzi A, Grosseto D, Tortorella G, Savonitto S, De Servi S. Clinical impact of valvular heart disease in elderly patients admitted for acute coronary syndrome: insights from the Elderly-ACS 2 Study. Can J Cardiol 2020 Jul;36(7):1104-1111.
• Somaschini A, Cornara S,Demarchi A, Mandurino-Mirizzi A, Fortuni F, Crimi G, Ferlini M, Camporotondo R, Gnecchi M, Oltrona-Visconti L, De Ferrari GM. Neutrophil to Platelet Ratio: A Novel Prognostic Biomarker in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention Eur J Preventive Cardiol 2019 27(19): 2338-2340.
• Somaschini A, Cornara S, Mandurino-Mirizzi A. The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of “dysflammaging”? J Cardiovasc Med 2020; 21 (4): 340-342.
• Mandurino-Mirizzi A, Demarchi A, Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction J Cardiovasc Med 2020; 21 (4):337-339.
• Crimi G, Mandurino-Mirizzi A, De-escalating dual antiplatelet therapy in patients with acute coronary syndromes: the right strategy to harmonize time-dependent ischemic and bleeding risk in elderly patients?. J Cardiovasc Med 2020; 21(4):281-285.
• Mandurino-Mirizzi A, Spolverini M, Attanasio A, Crimi G. Management of no-reflow: still an unsolved problem? J Phlebol Lymphol 2020;13(1):1-7.
• Demarchi A, Mazzucchelli I, Somaschini A, Cornara S, Dusi V, Mandurino-Mirizzi A, Ruffinazzi M, Crimi G, Ferlini M, Gnecchi M, Oltrona-Visconti L, De Servi S, De Ferrari GM. Leptin affects the inflammatory response after STEMI. Nutr Metab Cardiovasc Dis 2020 Jun 9;30(6):922-924.
• Montalto C, Morici N, Munafò A, Mangieri A, Mandurino-Mirizzi A, D’Ascenzo F, Oreglia J, Latib A, Porto I, Colombo A, Savonitto S, De Servi S, Crimi G Optimal P2Y12 inhinibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2020 Aug 24:pvaa101.
• Demarchi A, Cornara S, Somaschini A, Fortuni F, Mandurino-Mirizzi A, Crimi G, Ferlini M, Gnecchi M, De Servi S, Oltrona-Visconti L, De Ferrari GM. Has hyperglycemia a different prognostic role in STEMI patients without diabetes? Nutr Metab Cardiovasc Dis 2020 Sep 16.
• Montalto C, Ferlini M, Casula M, Mandurino-Mirizzi A, Costa F, Leonardi S, Oltrona-Visconti L. DAPT score to stratify ischemic and bleeding risk after PCI: an updated systematic review, meta-analysis and meta-regression of 100,211 patients. Thromb Haemostasis 2020 Nov 19.
• Mandurino-Mirizzi A, Cornara S, Somaschini A, Demarchi A, Galazzi M, Puccio S, Montalto C, Crimi G, Ferlini M, Camporotondo R, Gnecchi M, Ferrario M, Oltrona-Visconti L, De Ferrari GM. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Nutr Metab Cardiovasc Dis 2020
• Mandurino-Mirizzi A, Tua L, Arzuffi L, Demarchi A, Somaschini A, Tournas G, Crimi G, Androulakis E, Briasoulis A, Cornara S. Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives. Rev Cardiovasc Med 2021 Mar 30;22 (1):33-38.
• Mandurino-Mirizzi A, Kajana V, Cornara S, Somaschini A, Demarchi A, Galazzi M, Crimi G, Ferlini M, Camporotondo R, GNecchi M, Ferrario M, Oltron-Visconti L, De Ferrari GM. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patients with ST-segment elevated myocardial infarction undergoing primary percutaneous coronary intervention. Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2140-2143.
• Ferlini M, Leonardi S, Mandurino-Mirizzi A, Montalto C, Crimi G, Repetto A, Marinoni B, Somaschini A, Ferrario M, Klersy C, Oltrona Visconti L. Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction unergeoing primary percutaneous coronary intervention. J Cardiovasc Med 2021 Jun 1; 22(7):539-545.
• Wang X, Montero-Cabezas JM, Mandurino-Mirizzi A, Hirasawa K, Ajmone Marsan N, Knuuti J, Bax JJ, Delgado V. Prevalence and long-term outcomes of patients with coronary artery ectasia presenting with acute myocardial infarction. Am J Cardiol 2021 Jul 31:S0002-9149(21)00619.
• Mandurino-Mirizzi A, Arzuffi L, Negrello E, Crimi G, Ferlini M, Marinoni B, Repetto A, Mauri V, Marconi S, Ferrario M, Oltrona Visconti L. Right coronary artery atresia in an athlete presenting with cardiac arrest: a case report. Coron Artery Dis 2022 Jan 1;31(1):64-65.
• Mandurino-Mirizzi A, Crimi G, Raineri C, Magrini G, Gazzoli F, Frassica R, impect Gritti V, Montalto C, Scelsi L, Turco A, Ameri P, Ghio S, Ferrario M, Oltrona Visconti L. Hemodynamic impact of MitraClip in patients with functional mitral regurgitation and pulmonary hypertension. Eur J Clin Invest 2021 Dec;51(12):e13676.
• Somaschini A, Casirati A, Cornara S, Demarchi A, Mandurino-Mirizzi A, Androulakis E, Lioudaki E. Extracorporeal veno-venous ultrafiltration in patients with acute heart failure. Rev Cardiovasc Med 2021 Dec 22;22(4):1311-1322.
• Mandurino-Mirizzi A, Raineri C, Magrini G, Frassica R, Scelsi L, Turco A, Ghio S, Ferrario M, Oltrona-Visconti L, Crimi G. Iatrogenica trial septal defect does not affect acute hemodynamic modifications after transcatheter edge-to-edge repair in patients with functional mitral regurgitation. Hellenic J Cardiol 2022 Feb 25; S1109-9666(22)00023-9.
• Kajana V, Massaro G, Somaschini A, Cornara S, Demarchi A, Nardella E, Nicoletti A, Sangiorgi GM, Mandurino-Mirizzi A. Serum uric acid in patients with ST-segment elevation myocardial infarction: an innocent bystander or leading actor? Nutr Metab Cardiovasc Dis 2022
• Mandurino-Mirizzi A, Munafò A, Crimi G. Contrast-associated acute kidney injury. J Clin Med 2022, 11 (8), 2167.
• Mandurino-Mirizzi A, Munafò A, Raineri C, Magrini G, Frassica R, Arzuffi L, Scelsi L, Turco A, Ferlini M, Gazzoli F, Ferrario M, Ghio S, Oltrona-Visconti L, Crimi G. Response to acute vasodilator challenge and haemodynamic modifications after MitraClip in patients with functional mitral regurgitation and pulmonary hypertension. Eur Heart J Acute Cardiovasc Care 2022 Jun 22;11(6):464-469.
• Montalto C, Munafò A, Arzuffi L, Casula M, Mandurino-Mirizzi A, Costa F, Leonardi S, Oltrona-Visconti L, Ferlini M. Validation of the ARC-HBR criteria in 68874 patients undergoing PCI: a systematic review and meta-analysis. Hellenic J Cardiol 2022 Jul-Aug; 66:59-66.
• Ferlini M, Munafò A, Lanzillo G, Aiello M, Gazzoli F, Mandurino-Mirizzi A, Magrini G, Pelenghi S, Oltrona-Visconti L. Early surgical aortic valve replacement in asymptomatic patients with severe aortic stenosis: a systematic review and meta-analysis. J Cardiovasc Med 2022 Sep 1;23(9):632-634.
• Kajana V, Baldi E, Gentile FR, Compagnoni S, Quilico F, Vicini Scajola L, Repetto A, Mandurino-Mirizzi A, Ferlini M, Marinoni B, Ferrario M, Primi R, Bendotti S, Currao A, Savastano S. Complete revascularization and one-year survival with good neurological outcome in patients resuscitated from an out-of-hospital cardiac arrest. J Clin Med 2022 Aug 29;11(17):5071.
• Tua L, Mandurino-Mirizzi A, Colombo C, Morici N, Magrini G, Nava S, Frassica R, Montalto C, Ferlini M, Sacco A, Musca F, Moreo A, Ghio S, Oreglia J, Oltrona-Visconti L, Oliva F, Crimi G. The impact of transcatheter edge-to-edge repair on right ventricle-pulmonary artery coupling in patients with functional mitral regurgitation. Eur J Clin Invest 2023 Jan; 53(1):e13869.
• Arzuffi L, Mandurino-Mirizzi A, Magrini G, Frassica R, Disabato G, Ferlini M, Gazzoli F, Scelsi L, Turco A, Munafò A, Ghio S, Ferrario M, Oltrona-Visconti L, Crimi G. Impact of mitral transcatheter edge-to-edge repair on pulmonary vein flow in patients with functional mitral regurgitation. J Cardiovasc Med 2022;23:1-3.
• Ghio S, Mandurino-Mirizzi A, La Rovere MT, Traversi E, Lombardi C, Scelsi L, Senni M, Iacovoni A. Sodium nitroprusside for advanced heart failure. A metanalysis of literature data. Vascul Pharmacol 2023
• Mandurino-Mirizzi A, Crimi G. Do we need to know and monitor the Hemodynamics of patients treated with mitral transcatheter edge-to-edge repair? Am J Cardiol 2023.